Abstract: A reconfigurable battery pack is disclosed. The reconfigurable battery back includes plurality of reconfigurable units, such as cells, and switches or selectors coupled to the reconfigurable units within the reconfigurable battery pack. The switches or selectors can be controlled to reconfigure the electric connectivity among the reconfigurable units and to the loads having different power or voltage specifications that are directly connected to and powered by the reconfigurable battery pack.

Abstract: An electric door release system and an electric door release method are disclosed. The system and method may be used for releasing a vehicle door when a primary power source of the vehicle is drained. According to certain embodiments, the system includes a power interface configured to receive a direct-current (DC) power from an external mobile device. The system also includes one or more door latches. The system further includes an isolation circuitry configured to prevent the DC power from powering circuitry not included in the electric door release system. The system further includes a controller configured to activate a door latch using the DC power.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer, in particular myeloma. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to several novel peptide sequences and their variants derived from HLA class I and HLA class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.

Abstract: The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to several novel peptide sequences and their variants derived from HLA class I and HLA class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.

Abstract: A system and method for detecting pressure within a soft toy is presented. A soft toy has a soft toy body and an air bladder inside the soft toy body. A pressure sensing logic internal to the soft toy body measures a pressure of air inside the air bladder. When the pressure sensing logic measures air inside the air bladder is within a predetermined pressure range, control logic in the soft toy generates at least one output to at least one output device mounted in or on the soft toy.

Abstract: A control system and a method of using the same for an electric machine having a random number generating module generating a random number ranging from a first value to a second value, a multiplying module multiplying the random number and a sample rate to generate an random delay value; and a delay limiter module limiting the random delay value as a function of speed of the electric machine and generating a limited delay value.